Stemirna Therapeutics
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
604 Building 2 no. 1295 Chuanqiao Road P...Phone Number
+86 2151534970Website
www.stemirna.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Stemirna Therapeutics
Founded in 2016, Stemirna Therapeutics is a biotechnology company in China that focuses on mRNA-based vaccines and medicines. The company possesses a lipopolyplex (LPP) delivery platform as well as an industrial-level mRNA synthesis platform, and has made significant progress in pre-clinical research, with its personalized cancer vaccine reaching pre-IND clinical trials (investigator-initiated trials) in China. Stemirna's LPP-based delivery platform, with its signature core-shell structure, can selectively deliver mRNA to dendritic cells and achieve controlled release of mRNA in the cytosol, where it is then translated and presented to T cells.Explore more
Stemirna Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stemirna Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Stemirna Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Stemirna Therapeutics has new funding data
Product Launch: Get notified when Stemirna Therapeutics launches new products
Check out if Stemirna Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Stemirna Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Stemirna Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Stemirna Therapeutics
Website visits: Recent activity has been detected on your website
Click to see if Stemirna Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Stemirna Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Stemirna Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Stemirna Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Stemirna Therapeutics.
Stemirna Therapeutics financials insights
Gather financial insights about Stemirna Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$200M
Stemirna Therapeutics Tech Stack
A closer look at the technologies used by Stemirna Therapeutics
See more technologies
Stemirna Therapeutics News & Media
StemiRNA Therapeutics appoints Dr. Jack Hu as CFO - FutureCFO
At StemiRNA, the new CFO will oversee finance management and investor relations while providing support to the company's overall strategy planning and corporate developmentStemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer
SHANGHAI and BOSTON, Dec. 12, 2021 /PRNewswire/ -- StemiRNA, a leader in research and development of mRNA therapeutics, welcomes Dr. Jack Hu as Chief Financial Officer. Dr. Hu brings nearly two decades of experience in healthcare investment research, financial management and corporate...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stemirna Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2016, Stemirna Therapeutics is a biotechnology company in China that focuses on mRNA-based vaccines and medicines. The company possesses a lipopolyplex (LPP) delivery platform as well as an industrial-level mRNA synthesis platform, and has made significant progress in pre-clinical research, with its personalized cancer vaccine reaching p... Read More
